Assessment of patients with hereditary transthyretin amyloidosis – understanding the impact of management and disease progression

DOI Web Site 3 Citations

Isabel Conceição

CHLN-Hospital Santa Maria, IMM, Unversidade de Lisboa, Lisbon, Portugal;
Teresa Coelho

Unidade Corino de Andrade, Hospital de Santo António, Centro Hospitalar Universitário do Porto, Porto, Portugal;
Claudio Rapezzi

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy;
Yeşim Parman

Neurology Department, Neuromuscular Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey;
Laura Obici

IRCCS Fondazione Policlinico San Matteo, Amyloidosis Research and Treatment Center, Pavia, Italy;
Lucía Galán

Department of Neurology, Hospital Clinico San Carlos IdiSSC, Madrid, Spain;
Antoine Rousseau

Department of Ophthalmology, Bicêtre Hospital Université Paris-Sud, Le Kremlin-Bicêtre, France APHP, DHU Sight Restore, French Reference centre for H-ATTR (NNERF), French Reference Network for Rare Ophthalmic Diseases (OPHTARA), Le Kremlin-Bicêtre, France

Journal

Back to top